BRIEF-Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model

2

Sept 21 (Reuters) – Recursion Pharmaceuticals, Inc. : * TEMPUS AND RECURSION EXTEND EXISTING DATA LICENSE AGREEMENT AND ENTER NEW LICENSE AGREEMENT FOR RECURSION’S RNA FOUNDATION MODEL * TEMPUS AI, –

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)